文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

在重症医学中使用证据(似然)方法进行试验分析与解读:原理与实践考虑

Trial Analysis and Interpretation in Critical Care Using the Evidential (Likelihood) Approach: Rationale and Practical Considerations.
PubMed 文献 · Am J Respir Crit Care Med · 2025-01-01
一句话结论证据(似然)框架通过似然比、支持值和支持区间量化竞争假设间的相对证据,为重症试验提供补充传统P值的直观解读工具。

本文是一篇简明转化综述,介绍证据(似然)框架作为重症临床试验分析工具。作者以ART(N=1,010)、STAMINA(N=214)和BaSICS(N=10,520)三项试验数据演示该框架的应用,重点阐述似然比、支持值和支持区间等效应量度、在序贯分析与试验监测试中的应用建议以及结果报告方式。作者提出该框架聚焦竞争假设间的相对证据,提供与临床推理过程一致的补充见解,并开发了交互式Shiny应用便于实施。

要点

  • 证据(似然)框架以似然比、支持值和支持区间量化竞争假设间的相对证据,补充传统P值分析。
  • 作者用ART(N=1,010)、STAMINA(N=214)和BaSICS(N=10,520)三项机械通气与平衡液试验数据演示该框架的应用。
  • 该框架可用于序贯分析与试验监测,并给出了研究论文中报告结果的建议。
  • 作者认为该框架提供临床直观的试验解读方式,与临床推理过程一致,并提供交互式Shiny应用辅助实施。

适用人群与场景

  • 重症医学领域的临床试验数据,示例包括机械通气试验ART(N=1,010)和STAMINA(N=214)以及平衡液试验BaSICS(N=10,520)。

研究设计与关键结果

  • 本文为简明转化综述,介绍证据(似然)框架并利用ART(N=1,010)、STAMINA(N=214)和BaSICS(N=10,520)三项试验数据演示其应用。
  • 文中阐述了该框架的效应量度(似然比、支持值和支持区间)、在序贯分析与试验监测中的使用建议以及研究论文中的报告方式。
  • 作者提出证据框架聚焦竞争假设间的相对证据,提供与传统P值分析互补的临床直观解读,并开发了交互式Shiny应用(https://fzampier.shinyapps.io/Likelihood_Shiny/)便于科学界实施。

证据类型、等级与局限

  • 证据类型:简明转化综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为证据(似然)框架提供临床直观的试验解读方法,可补充传统P值分析,帮助理解重症试验中竞争假设间的相对证据。
  • 作者开发了交互式Shiny应用供科学界实施该框架。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Selecting the optimal methodological framework for evidence synthesis presents a fundamental challenge in contemporary clinical research. In critical care, in which many interventions yield inconclusive results under traditional P value-based analyses, complementary analytical approaches can enhance our understanding of trial data. Although frequentist statistics remain predominant and Bayesian methods have recently experienced a resurgence of interest, the evidential (or likelihood) framework offers a methodological perspective that potentially bridges these two inferential paradigms. In this Concise Translational Review, we introduce readers to the evidential approach. To present the evidential approach as an analytical tool for critical care trials, we demonstrate its application using data from two mechanical ventilation trials (ART [the Alveolar Recruitment Trial], N = 1,010; and STAMINA [Strategy for Community Acquired Pneumonia Trial], N = 214) and one trial evaluating balanced solutions (BaSICS [Balanced Solutions in Intensive Care Study], N = 10,520). We focus on how concepts and terminology translate across paradigms, the framework's measures of effect (i.e., likelihood ratios, support values, and support intervals), proposals for its use in sequential analysis and trial monitoring, and how to report results from this framework in research articles. We propose that the evidential framework provides a clinically intuitive approach to trial interpretation by focusing on the relative evidence between competing hypotheses, thereby offering additional and complementary insights that align with clinical reasoning processes. To facilitate implementation by the scientific community, we have developed an interactive Shiny (open-source web-based) application (https://fzampier.shinyapps.io/Likelihood_Shiny/).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Zampieri FG, Cahusac PMB, Maia IS, et al. Trial Analysis and Interpretation in Critical Care Using the Evidential (Likelihood) Approach: Rationale and Practical Considerations. Am J Respir Crit Care Med. 2025. PMID: 40591921. doi:10.1164/rccm.202504-0809TR

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。